388 related articles for article (PubMed ID: 30833373)
21. One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study.
Faulconbridge LF; Wadden TA; Rubin RR; Wing RR; Walkup MP; Fabricatore AN; Coday M; Van Dorsten B; Mount DL; Ewing LJ;
Obesity (Silver Spring); 2012 Apr; 20(4):783-93. PubMed ID: 22016099
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant Effect of the VA Weight Management Program (MOVE) Among Veterans With Severe Obesity.
Shiroma PR; Velasquez T; Usset TJ; Wilhelm JH; Thuras P; Baltutis E
Mil Med; 2020 Jun; 185(5-6):e586-e591. PubMed ID: 32077960
[TBL] [Abstract][Full Text] [Related]
23. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
Weitz ES; Hollon SD; Twisk J; van Straten A; Huibers MJ; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Cristea IA; Faramarzi M; Hegerl U; Jarrett RB; Kheirkhah F; Kennedy SH; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Vittengl JR; Cuijpers P
JAMA Psychiatry; 2015 Nov; 72(11):1102-9. PubMed ID: 26397232
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and correlates of depression in individuals with and without type 1 diabetes.
Gendelman N; Snell-Bergeon JK; McFann K; Kinney G; Paul Wadwa R; Bishop F; Rewers M; Maahs DM
Diabetes Care; 2009 Apr; 32(4):575-9. PubMed ID: 19171719
[TBL] [Abstract][Full Text] [Related]
25. Depression, antidepressants and the risk of cardiovascular events and death in older men.
Almeida OP; Ford AH; Hankey GJ; Golledge J; Yeap BB; Flicker L
Maturitas; 2019 Oct; 128():4-9. PubMed ID: 31561821
[TBL] [Abstract][Full Text] [Related]
26. Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.
Kaze AD; Santhanam P; Erqou S; Bertoni AG; Ahima RS; Echouffo-Tcheugui JB
Diabetes Res Clin Pract; 2021 Jun; 176():108859. PubMed ID: 33989668
[TBL] [Abstract][Full Text] [Related]
27. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
Wannamethee SG; Shaper AG; Walker M
J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
[TBL] [Abstract][Full Text] [Related]
28. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.
Pan A; Sun Q; Okereke OI; Rexrode KM; Rubin RR; Lucas M; Willett WC; Manson JE; Hu FB
Diabetologia; 2012 Jan; 55(1):63-72. PubMed ID: 21811871
[TBL] [Abstract][Full Text] [Related]
29. Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1.
Belalcazar LM; Anderson AM; Lang W; Schwenke DC; Haffner SM; Yatsuya H; Rushing J; Vitolins MZ; Reeves R; Pi-Sunyer FX; Tracy RP; Ballantyne CM;
J Acad Nutr Diet; 2014 Nov; 114(11):1800-10.e2. PubMed ID: 25131348
[TBL] [Abstract][Full Text] [Related]
30. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
Ryan DH; Espeland MA; Foster GD; Haffner SM; Hubbard VS; Johnson KC; Kahn SE; Knowler WC; Yanovski SZ;
Control Clin Trials; 2003 Oct; 24(5):610-28. PubMed ID: 14500058
[TBL] [Abstract][Full Text] [Related]
31. Elucidating the Association Between Depressive Symptoms, Coronary Heart Disease, and Stroke in Black and White Adults: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.
Moise N; Khodneva Y; Richman J; Shimbo D; Kronish I; Safford MM
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27521153
[TBL] [Abstract][Full Text] [Related]
32. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.
Vaccarino V; Johnson BD; Sheps DS; Reis SE; Kelsey SF; Bittner V; Rutledge T; Shaw LJ; Sopko G; Bairey Merz CN;
J Am Coll Cardiol; 2007 Nov; 50(21):2044-50. PubMed ID: 18021871
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial.
de Vries TI; Dorresteijn JAN; van der Graaf Y; Visseren FLJ; Westerink J
Diabetes Care; 2019 Oct; 42(10):1988-1994. PubMed ID: 31416897
[TBL] [Abstract][Full Text] [Related]
34. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Rutledge T; Linke SE; Krantz DS; Johnson BD; Bittner V; Eastwood JA; Eteiba W; Pepine CJ; Vaccarino V; Francis J; Vido DA; Merz CN
Psychosom Med; 2009 Nov; 71(9):958-64. PubMed ID: 19834049
[TBL] [Abstract][Full Text] [Related]
35. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
[TBL] [Abstract][Full Text] [Related]
36. The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severity.
May HT; Bair TL; Reiss-Brennan B; Knight S; Anderson JL; Horne BD; Brunisholz KD; Muhlestein JB
Psychol Health Med; 2017 Sep; 22(8):919-931. PubMed ID: 28111972
[TBL] [Abstract][Full Text] [Related]
37. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.
; Bray G; Gregg E; Haffner S; Pi-Sunyer XF; WagenKnecht LE; Walkup M; Wing R
Diab Vasc Dis Res; 2006 Dec; 3(3):202-15. PubMed ID: 17160917
[TBL] [Abstract][Full Text] [Related]
38. The LEADER trial in type 2 diabetes: Were the characteristics and outcomes of the participants representative?
Davis TME; Davis WA
J Diabetes Complications; 2019 Jun; 33(6):427-433. PubMed ID: 31003926
[TBL] [Abstract][Full Text] [Related]
39. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
[TBL] [Abstract][Full Text] [Related]
40. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.
Baum A; Scarpa J; Bruzelius E; Tamler R; Basu S; Faghmous J
Lancet Diabetes Endocrinol; 2017 Oct; 5(10):808-815. PubMed ID: 28711469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
